JP2004175807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004175807A5 JP2004175807A5 JP2004027473A JP2004027473A JP2004175807A5 JP 2004175807 A5 JP2004175807 A5 JP 2004175807A5 JP 2004027473 A JP2004027473 A JP 2004027473A JP 2004027473 A JP2004027473 A JP 2004027473A JP 2004175807 A5 JP2004175807 A5 JP 2004175807A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- formula
- ring
- pharmaceutically acceptable
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000651 prodrug Substances 0.000 claims 33
- 229940002612 prodrug Drugs 0.000 claims 33
- 150000003839 salts Chemical class 0.000 claims 33
- 239000012453 solvate Substances 0.000 claims 32
- 125000001424 substituent group Chemical group 0.000 claims 30
- 150000001875 compounds Chemical class 0.000 claims 24
- 229910052736 halogen Inorganic materials 0.000 claims 21
- 150000002367 halogens Chemical class 0.000 claims 21
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 239000001257 hydrogen Substances 0.000 claims 17
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 125000002947 alkylene group Chemical group 0.000 claims 15
- 125000001072 heteroaryl group Chemical group 0.000 claims 15
- 125000003107 substituted aryl group Chemical group 0.000 claims 14
- 125000004429 atom Chemical group 0.000 claims 13
- 125000001188 haloalkyl group Chemical group 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 11
- -1 hydroxy, mercapto Chemical group 0.000 claims 11
- 150000001540 azides Chemical class 0.000 claims 10
- 125000004450 alkenylene group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 7
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 5
- 125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- YIBBMDDEXKBIAM-UHFFFAOYSA-M potassium;pentoxymethanedithioate Chemical compound [K+].CCCCCOC([S-])=S YIBBMDDEXKBIAM-UHFFFAOYSA-M 0.000 claims 4
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 4
- 125000004521 1,3,4-thiadiazol-2-yl group Chemical group S1C(=NN=C1)* 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000005368 heteroarylthio group Chemical group 0.000 claims 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 2
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 2
- 125000005530 alkylenedioxy group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 2
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 2
- 125000005110 aryl thio group Chemical group 0.000 claims 2
- 125000005164 aryl thioalkyl group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 claims 2
- 125000004438 haloalkoxy group Chemical group 0.000 claims 2
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 2
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 claims 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 2
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims 2
- IRSGOAFJPADUHK-UHFFFAOYSA-N 1-(5-benzyl-8-hydroxyquinolin-7-yl)ethanone Chemical compound C=12C=CC=NC2=C(O)C(C(=O)C)=CC=1CC1=CC=CC=C1 IRSGOAFJPADUHK-UHFFFAOYSA-N 0.000 claims 1
- JZVCTHJWXFRYKG-UHFFFAOYSA-N 1-(8-hydroxy-5-phenylquinolin-7-yl)ethanone Chemical compound C=12C=CC=NC2=C(O)C(C(=O)C)=CC=1C1=CC=CC=C1 JZVCTHJWXFRYKG-UHFFFAOYSA-N 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 229940099797 HIV integrase inhibitor Drugs 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000003302 alkenyloxy group Chemical group 0.000 claims 1
- 150000004703 alkoxides Chemical class 0.000 claims 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 claims 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 239000003084 hiv integrase inhibitor Substances 0.000 claims 1
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims 1
- LHKVDVFVJMYULK-UHFFFAOYSA-N nitrosylazide Chemical compound [N-]=[N+]=NN=O LHKVDVFVJMYULK-UHFFFAOYSA-N 0.000 claims 1
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 claims 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 125000000464 thioxo group Chemical group S=* 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004027473A JP4367762B2 (ja) | 2001-03-01 | 2004-02-04 | Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001057037 | 2001-03-01 | ||
| JP2001243530 | 2001-08-10 | ||
| JP2001395022 | 2001-12-26 | ||
| JP2004027473A JP4367762B2 (ja) | 2001-03-01 | 2004-02-04 | Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002569806A Division JP3616628B2 (ja) | 2001-03-01 | 2002-02-27 | Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004175807A JP2004175807A (ja) | 2004-06-24 |
| JP2004175807A5 true JP2004175807A5 (enExample) | 2005-06-23 |
| JP4367762B2 JP4367762B2 (ja) | 2009-11-18 |
Family
ID=27346141
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002569806A Expired - Fee Related JP3616628B2 (ja) | 2001-03-01 | 2002-02-27 | Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 |
| JP2004027473A Expired - Fee Related JP4367762B2 (ja) | 2001-03-01 | 2004-02-04 | Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002569806A Expired - Fee Related JP3616628B2 (ja) | 2001-03-01 | 2002-02-27 | Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7148237B2 (enExample) |
| EP (2) | EP1375486B1 (enExample) |
| JP (2) | JP3616628B2 (enExample) |
| KR (1) | KR20030078958A (enExample) |
| CN (1) | CN1659143A (enExample) |
| AT (1) | ATE411292T1 (enExample) |
| BR (1) | BR0207809A (enExample) |
| CA (1) | CA2439666A1 (enExample) |
| CZ (1) | CZ20032332A3 (enExample) |
| DE (1) | DE60229364D1 (enExample) |
| HU (1) | HUP0400175A2 (enExample) |
| IL (1) | IL157638A0 (enExample) |
| MX (1) | MXPA03007765A (enExample) |
| NO (1) | NO20033848L (enExample) |
| PL (1) | PL365027A1 (enExample) |
| WO (1) | WO2002070486A1 (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ511255A (en) * | 2001-04-20 | 2003-12-19 | Deep Video Imaging Ltd | Multi-focal plane display having an optical retarder and a diffuser interposed between its screens |
| BR0211750A (pt) | 2001-08-10 | 2004-10-13 | Shionogi & Co | Agente antiviral |
| DE10145457A1 (de) * | 2001-09-14 | 2003-04-03 | Basf Ag | Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen |
| MXPA04003932A (es) * | 2001-10-26 | 2004-06-18 | Angeletti P Ist Richerche Bio | Inhibidores de la hidroxipirimidinona carboxamida n-sustituida de la integrasa del virus de inmunodeficiencia humana. |
| DE60218511T2 (de) * | 2001-10-26 | 2007-10-25 | Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase |
| JP4494020B2 (ja) * | 2002-03-15 | 2010-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド |
| WO2004024693A1 (ja) * | 2002-08-13 | 2004-03-25 | Shionogi & Co., Ltd. | Ｈｉｖインテグラーゼ阻害活性を有するヘテロ環化合物 |
| PA8586801A1 (es) | 2002-10-31 | 2005-02-04 | Pfizer | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso |
| NZ533641A (en) | 2002-11-20 | 2006-07-28 | Japan Tobacco Inc | 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors |
| CA2513141A1 (en) | 2003-01-27 | 2004-08-12 | Pfizer Inc. | Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| JP2006528694A (ja) * | 2003-05-13 | 2006-12-21 | スミスクライン ビーチャム コーポレーション | ナフチリジンインテグラーゼインヒビター |
| CN1318424C (zh) * | 2003-06-18 | 2007-05-30 | 复旦大学 | 芳杂环羧酸衍生物，制备方法及在药学上的应用 |
| JP4859676B2 (ja) | 2004-02-11 | 2012-01-25 | スミスクライン ビーチャム コーポレーション | Ｈｉｖインテグラーゼ阻害剤 |
| EA200601654A1 (ru) * | 2004-03-09 | 2007-02-27 | Мерк Энд Ко., Инк. | Ингибиторы интегразы вич |
| CA2563761C (en) | 2004-04-26 | 2009-12-29 | Pfizer Inc. | Inhibitors of the hiv integrase enzyme |
| MXPA06012449A (es) | 2004-04-26 | 2007-01-17 | Pfizer | Inhibidores de la enzima integrasa de vih. |
| MY134672A (en) | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
| WO2005113509A1 (en) * | 2004-05-20 | 2005-12-01 | Japan Tobacco Inc. | Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| EP2229945A1 (en) | 2004-05-21 | 2010-09-22 | Japan Tobacco, Inc. | Combinations comprising a 4-isoquinolone derivative and anti-HIV agents |
| WO2005121132A1 (ja) * | 2004-06-11 | 2005-12-22 | Shionogi & Co., Ltd. | 抗ｈｃｖ作用を有する縮合ヘテロ環化合物 |
| CN101076531A (zh) | 2004-10-12 | 2007-11-21 | 解码遗传学公司 | 用于阻塞性血管疾病的羧酸迫位取代的双环化合物 |
| US7674822B2 (en) | 2004-11-24 | 2010-03-09 | Wyeth | PTP1b inhibitors |
| CA2610029A1 (en) * | 2005-06-01 | 2006-12-07 | Bioalliance Pharma | Synergic combinations comprising a quinoline compound and other hiv infection therapeutic agents |
| PT1928457E (pt) * | 2005-09-30 | 2013-02-19 | Pulmagen Therapeutics Asthma Ltd | Quinolinas e sua utilização terapêutica |
| JP5094725B2 (ja) * | 2005-10-04 | 2012-12-12 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ | Ｈｉｖインテグラーゼ阻害剤 |
| EP2452682A1 (en) * | 2006-02-01 | 2012-05-16 | Japan Tobacco, Inc. | Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| CN102633783A (zh) | 2006-02-10 | 2012-08-15 | 转化技术制药公司 | 作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法 |
| ES2531190T3 (es) | 2006-03-06 | 2015-03-11 | Japan Tobacco Inc | Método para producir un compuesto de 4-oxoquinolina |
| WO2007122482A1 (en) * | 2006-04-20 | 2007-11-01 | Pfizer Products Inc. | Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases |
| EP2079699A1 (en) * | 2006-07-25 | 2009-07-22 | Envivo Pharmaceuticals, Inc. | Quinoline derivatives |
| SI2091948T1 (sl) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novi inhibitorji glutaminil ciklaze |
| JP2010535804A (ja) * | 2007-08-09 | 2010-11-25 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Ｐｉ３キナーゼ阻害薬としてのキノキサリン誘導体 |
| JP2012507530A (ja) * | 2008-10-29 | 2012-03-29 | メルク・シャープ・エンド・ドーム・コーポレイション | 有用な抗糖尿病剤である新規な環状ベンズイミダゾール誘導体 |
| FR2938538B1 (fr) * | 2008-11-17 | 2011-08-05 | Univ Nice Sophia Antipolis | Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique |
| GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
| BRPI1015135B1 (pt) | 2009-06-29 | 2021-08-03 | Incyte Holdings Corporation | Pirimidinonas inibidoras de pi3k, composição compreendendo tais compostos, bem como usos dos mesmos |
| GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
| US8759359B2 (en) * | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
| WO2011075630A1 (en) * | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| PT2516008E (pt) * | 2009-12-23 | 2014-07-16 | Univ Leuven Kath | Novos compostos antivirais |
| EP2345643A1 (en) | 2009-12-29 | 2011-07-20 | Polichem S.A. | New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| EP2345641A1 (en) | 2009-12-29 | 2011-07-20 | Polichem S.A. | New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| EP2345642A1 (en) * | 2009-12-29 | 2011-07-20 | Polichem S.A. | Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| CA2796311A1 (en) | 2010-04-14 | 2011-10-20 | Incyte Corporation | Fused derivatives as pi3k.delta. inhibitors |
| WO2011163195A1 (en) | 2010-06-21 | 2011-12-29 | Incyte Corporation | Fused pyrrole derivatives as pi3k inhibitors |
| SG186877A1 (en) | 2010-06-30 | 2013-02-28 | Fujifilm Corp | Novel nicotinamide derivatives or salts thereof |
| US8633200B2 (en) * | 2010-09-08 | 2014-01-21 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
| MX2013005478A (es) | 2010-11-15 | 2013-08-29 | Univ Leuven Kath | Compuestos heterociclicos condensados antivirales. |
| CA2822070C (en) | 2010-12-20 | 2019-09-17 | Incyte Corporation | N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
| WO2012125629A1 (en) | 2011-03-14 | 2012-09-20 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors |
| US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
| DK3513793T3 (da) | 2011-09-02 | 2021-04-26 | Incyte Holdings Corp | Heterocyclylaminer som pi3k-inhibitorer |
| CN107898790B (zh) | 2011-11-30 | 2024-06-21 | 埃默里大学 | 用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂 |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| CA2915622C (en) | 2013-06-21 | 2020-08-18 | Zenith Epigenetics Corp. | Novel substituted bicyclic compounds as bromodomain inhibitors |
| MX365864B (es) | 2013-06-21 | 2019-06-18 | Zenith Epigenetics Ltd | Inhibidores de bromodominio biciclicos novedosos. |
| EA201690087A1 (ru) | 2013-07-31 | 2016-08-31 | Зенит Эпидженетикс Корп. | Новые квиназолиноны как ингибиторы бромодомена |
| CN103554019B (zh) * | 2013-09-30 | 2015-08-05 | 浙江工业大学 | 一种甲溴羟喹的合成方法 |
| CN104140402B (zh) * | 2014-05-27 | 2016-01-20 | 天津市斯芬克司药物研发有限公司 | 一种苯并噻唑类化合物及其制备方法 |
| US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
| CN104447547B (zh) * | 2014-11-10 | 2017-04-19 | 苏州康润医药有限公司 | 4‑氨基异喹啉‑8‑甲酸甲酯的合成方法 |
| CN104447543B (zh) * | 2014-11-10 | 2016-08-24 | 苏州康润医药有限公司 | 3-氨基-7，8-二氟喹啉及其中间体的合成方法 |
| WO2016087936A1 (en) | 2014-12-01 | 2016-06-09 | Zenith Epigenetics Corp. | Substituted pyridinones as bromodomain inhibitors |
| CN107207474B (zh) | 2014-12-11 | 2021-05-07 | 恒翼生物医药科技(上海)有限公司 | 被取代的杂环作为溴结构域抑制剂 |
| JP2017538721A (ja) | 2014-12-17 | 2017-12-28 | ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． | ブロモドメインの阻害剤 |
| MX373232B (es) | 2015-02-27 | 2020-05-08 | Incyte Holdings Corp | Sales del inhibidor fosfoinositida 3-cinasa (pi3k) y procesos para su preparación. |
| WO2016183063A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Crystalline forms of a pi3k inhibitor |
| WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| MA52761A (fr) | 2018-06-01 | 2021-04-14 | Incyte Corp | Schéma posologique destiné au traitement de troubles liés à la pi3k |
| WO2020061103A1 (en) | 2018-09-18 | 2020-03-26 | Nikang Therapeutics, Inc. | Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH370082A (de) * | 1958-12-06 | 1963-06-30 | Geigy Ag J R | Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen |
| CH385846A (de) | 1960-03-31 | 1964-12-31 | Geigy Ag J R | Verfahren zur Herstellung von neuen 7-Acyl-8-hydroxy-chinolinen und ihre Verwendung als Fungizide und Bakterizide im Pflanzen- und Materialschutz |
| JPS5417754B2 (enExample) * | 1972-12-15 | 1979-07-02 | ||
| JPS587637B2 (ja) * | 1973-12-27 | 1983-02-10 | 住友化学工業株式会社 | シンキペニシリンノ セイホウ |
| JPS5227794A (en) | 1975-08-29 | 1977-03-02 | Sumitomo Chem Co Ltd | Preparation of synthesis of nnacylaminoo arylacetamido cephalosporin s |
| JPS5268193A (en) * | 1975-11-28 | 1977-06-06 | Sumitomo Chem Co Ltd | Synthesis of novel cephalosporin derivatives |
| JPS5293790A (en) | 1976-02-02 | 1977-08-06 | Sumitomo Chem Co Ltd | 7-(n-acylamino-alpha-arylacetamide) cephalosporins |
| JPH0527385A (ja) | 1991-07-24 | 1993-02-05 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
| US5681832A (en) * | 1995-02-17 | 1997-10-28 | The United States Of America As Represented By The Department Of Health And Human Services | Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity |
| US6310211B1 (en) * | 1996-09-10 | 2001-10-30 | Pharmacia & Upjohn Company | 8-hydroxy-7-substituted quinolines as anti-viral agents |
| FR2761687B1 (fr) | 1997-04-08 | 2000-09-15 | Centre Nat Rech Scient | Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques |
| WO1999050245A1 (en) | 1998-03-26 | 1999-10-07 | Shionogi & Co., Ltd. | Indole derivatives with antiviral activity |
| CA2333771A1 (en) | 1998-06-03 | 1999-12-09 | Mark W. Embrey | Hiv integrase inhibitors |
| AU756826C (en) | 1998-06-03 | 2003-08-21 | Merck & Co., Inc. | HIV integrase inhibitors |
| WO1999062520A1 (en) | 1998-06-03 | 1999-12-09 | Merck & Co., Inc. | Hiv integrase inhibitors |
| CA2370500A1 (en) | 1999-06-25 | 2001-01-04 | Lekhanh O. Tran | 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| EE200300145A (et) | 2000-10-12 | 2003-06-16 | Merck & Co., Inc. | Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon |
| JP4287649B2 (ja) | 2000-10-12 | 2009-07-01 | メルク エンド カムパニー インコーポレーテッド | Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類 |
| US20050010048A1 (en) | 2000-10-12 | 2005-01-13 | Linghang Zhuang | Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
| CA2425625A1 (en) | 2000-10-12 | 2002-07-18 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
-
2002
- 2002-02-27 CN CN028089219A patent/CN1659143A/zh active Pending
- 2002-02-27 IL IL15763802A patent/IL157638A0/xx unknown
- 2002-02-27 MX MXPA03007765A patent/MXPA03007765A/es unknown
- 2002-02-27 DE DE60229364T patent/DE60229364D1/de not_active Expired - Lifetime
- 2002-02-27 BR BR0207809-0A patent/BR0207809A/pt not_active Application Discontinuation
- 2002-02-27 CA CA002439666A patent/CA2439666A1/en not_active Abandoned
- 2002-02-27 EP EP02701583A patent/EP1375486B1/en not_active Expired - Lifetime
- 2002-02-27 HU HU0400175A patent/HUP0400175A2/hu unknown
- 2002-02-27 AT AT02701583T patent/ATE411292T1/de not_active IP Right Cessation
- 2002-02-27 JP JP2002569806A patent/JP3616628B2/ja not_active Expired - Fee Related
- 2002-02-27 WO PCT/JP2002/001778 patent/WO2002070486A1/ja not_active Ceased
- 2002-02-27 US US10/469,364 patent/US7148237B2/en not_active Expired - Fee Related
- 2002-02-27 EP EP08166487A patent/EP2033952B1/en not_active Expired - Lifetime
- 2002-02-27 CZ CZ20032332A patent/CZ20032332A3/cs unknown
- 2002-02-27 KR KR10-2003-7011406A patent/KR20030078958A/ko not_active Withdrawn
- 2002-02-27 PL PL02365027A patent/PL365027A1/xx not_active Application Discontinuation
-
2003
- 2003-08-29 NO NO20033848A patent/NO20033848L/no not_active Application Discontinuation
-
2004
- 2004-02-04 JP JP2004027473A patent/JP4367762B2/ja not_active Expired - Fee Related
-
2006
- 2006-08-08 US US11/500,387 patent/US7759372B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004175807A5 (enExample) | ||
| Wang et al. | Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4, 7-dimethoxy-1 H-pyrrolo [2, 3-c] pyridin-3-yl) ethane-1, 2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjects | |
| JP2010513322A5 (enExample) | ||
| Yeung et al. | Inhibitors of HIV-1 attachment. Part 7: indole-7-carboxamides as potent and orally bioavailable antiviral agents | |
| JP2006517220A5 (enExample) | ||
| JP2007504241A5 (enExample) | ||
| DK3042894T1 (da) | Antiviralt middel | |
| JP2011521911A5 (enExample) | ||
| KR102534262B1 (ko) | 헤테로환형 유도체 및 이의 용도 | |
| RU2010121763A (ru) | Производные пиридазинона и ингибиторы р2х7 рецептора | |
| NZ590126A (en) | Compounds having antiviral properties | |
| JP2018519245A5 (enExample) | ||
| JP2016505042A5 (enExample) | ||
| JP2011518163A5 (enExample) | ||
| JP2004506736A5 (enExample) | ||
| EP1829858A3 (en) | Dibenzylamine compounds and pharmaceutical use thereof | |
| JP2014514360A5 (enExample) | ||
| JP2016536364A5 (enExample) | ||
| JP2008510828A5 (enExample) | ||
| RU2012129168A (ru) | Производные оксазина | |
| JP2011520906A5 (enExample) | ||
| JP2010501478A5 (enExample) | ||
| JP2011504935A5 (enExample) | ||
| JP2011519374A5 (enExample) | ||
| JP2005509038A5 (enExample) |